The impact of calcium is often influenced by its molecular form within the systemic circulation. While many traditional supplements deliver calcium as complexed salts requiring metabolic conversion, Sigma Anti-bonding Calcium Carbonate (SAC^®) is designed to provide calcium in a highly soluble, ionized form (Ca²⁺)

Upon entry into the extracellular environment, SAC®-delivered calcium interacts with the Calcium-Sensing Receptor (CaSR). This interaction supports natural signal transduction pathways that help the body manage its internal mineral balance and support healthy skeletal turnover with:

• Systemic Mineral Balancing: By providing immediate access to active ions, SAC® helps the body maintain a balanced internal state, supporting natural bone-retention signals.
• Structural Optimization: This optimized environment supports the body’s internal signaling for mineral density and healthy skeletal turnover.

A key component of long-term wellness is maintaining the natural integrity of the vascular system. Because SAC^® technology focuses on high solubility and ionized delivery, it supports the body’s natural processes for utilizing minerals where they are needed most, primarily for structural support in the bones. This nutritional approach aligns with the body's natural homeostatic mechanisms for mineral distribution.

By bypassing the traditional digestive breakdown of calcium salts, SAC^® formula provides a bio-signaling advantage that aligns with the body's natural mineral homeostasis. This supports a balanced internal environment without the "spikes" often associated with traditional high-dose mineral supplementation

Educational Purpose Only: The technical information regarding SAC^® Formulation Technology, including discussions on molecular speciation and vascular homeostasis, is provided for educational and informational purposes only. It is intended to demonstrate the biochemical pathways associated with the proprietary SAC^® process and should not be construed as medical advice.

No Doctor-Patient Relationship: Accessing this technical data does not establish a professional relationship. The mechanisms described (e.g., CaSR-mediated signal transduction) refer to cellular-level research and may not reflect individual clinical outcomes.

Consultation: Consumers should consult with a qualified healthcare professional before starting any new supplementation protocol, especially those with pre-existing cardiovascular or renal conditions.

Lee, S. W., et al. "The Effects of Sigma Anti-bonding Calcium Carbonate on Bone Mineral Density." (Often cited in Marah-Cel/SAC internal whitepapers regarding the Ca²⁺ delivery system).

Journal of Bone and Mineral Metabolism: Specifically for the role of ionized calcium in inhibiting PTH.

CaSR & Bone Signaling: Brown, E. M., & MacLeod, R. J. (2001). "Extracellular Calcium-Sensing Receptors: Their Role in Regulation of Parathyroid Cells and Other Systems." Physiological Reviews.

Vascular Calcification (VSMCs): Shao, J. S., et al. (2006). "Vascular Calcification: The Pathobiology of Smooth Muscle Cell Phenotype Transdifferentiation." Journal of Clinical Investigation.

Matrix Gla Protein (MGP): Schurgers, L. J., et al. (2008). "Matrix Gla-protein: The Calcification Inhibitor in Bone and Blood Vessels."